Used primarily in pharmaceutical research as a chiral building block for the synthesis of neuroactive compounds. It serves as an intermediate in the development of nicotinic acetylcholine receptor (nAChR) modulators, which are investigated for treating neurological disorders such as depression, cognitive impairment, and neuropathic pain. Its structural configuration allows selective interaction with receptor subtypes, making it valuable in structure-activity relationship (SAR) studies. Also employed in the preparation of radiolabeled derivatives for use in receptor binding assays and positron emission tomography (PET) imaging probes.